Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular tranexamic acid to prevent heavy bleeding after childbirth in women at higher risk
ISRCTN12590098Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Apr 2024
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in postpartum hemorrhage (PPH) (3 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoints: Postpartum haemorrhage within 24 hours of birth and Haemodynamic instability within 24 hours. Started Apr 2024; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on ISRCTN12590098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12590098.